sp. nov., a Pathogen on and .

Eur J Plant Pathol

5Plants Bank, Iranian Biological Resource Center (IBRC), Academic Center for Education, Culture and Research (ACECR), Tehran, Iran.

Published: January 2018

Two strains, isolated from in Italy and in Vietnam respectively, proved to be members of an undescribed clade within the species complex based on phylogenetic species recognition on ITS, partial RPB2 and EF-1α gene fragments. Macro- and micro-morphological investigations followed with physiological studies done on this new species: can be distinguished by its conidial morphology. Both isolates of were shown to be pathogenic to the monocot when inoculated on roots and induced hollow root symptoms within two weeks in seedlings. In comparison mild disease symptoms were observed by the same strains on seedlings.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445495PMC
http://dx.doi.org/10.1007/s10658-017-1403-6DOI Listing

Publication Analysis

Top Keywords

nov pathogen
4
pathogen strains
4
strains isolated
4
isolated italy
4
italy vietnam
4
vietnam proved
4
proved members
4
members undescribed
4
undescribed clade
4
clade species
4

Similar Publications

A Novel Subspecies of Causing Leaf Spot in East Asian Hogweed.

Mycobiology

December 2024

Global Agro-Consulting Corporation, Suwon, Republic of Korea.

During disease surveys in 2021 and 2022, outbreaks of leaf spot were observed in East Asian hogweed () plants in fields located in Pyeongchang and Yeongwol, Gangwon Province, Korea. The disease incidence in the fields ranged from 2% to 50%. Based on the morphological and cultural characteristics, four single-conidium fungal isolates from the leaf spot symptoms were identified as sp.

View Article and Find Full Text PDF

Polymicrobial infection in cystic fibrosis and future perspectives for improving Mycobacterium abscessus drug discovery.

NPJ Antimicrob Resist

November 2024

College of Health and Life Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK.

Polymicrobial communities inhabit the cystic fibrosis (CF) airway, whereby microbial interactions can occur. One prominent CF pathogen is Mycobacterium abscessus, whose treatment is largely unsuccessful. This creates a need to discover novel antimicrobial agents to treat M.

View Article and Find Full Text PDF

Antimicrobial resistance is one of the major health threats of the modern world. Thus, new structural classes of antimicrobial compounds are needed in order to overcome existing resistance. Cystobactamids represent one such new compound class that inhibit the well-established target bacterial type II topoisomerases while exhibiting superior antibacterial and resistance-breaking properties.

View Article and Find Full Text PDF

Mycobacterium abscessus complex (MABSC) comprises a group of environmental microorganisms, which are a concerning cause of opportunistic respiratory infections in patients with cystic fibrosis or bronchiectasis. Only 45.6% of MABSC treatments are successful, and therefore this is a need to discover new antimicrobials that can treat these pathogens.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!